Literature DB >> 31925406

Dissecting the mechanisms of immune checkpoint therapy.

Padmanee Sharma1,2, James P Allison3.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31925406     DOI： 10.1038/s41577-020-0275-8

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.

Authors:  Sangeeta Goswami; Thomas Walle; Andrew E Cornish; Sreyashi Basu; Swetha Anandhan; Irina Fernandez; Luis Vence; Jorge Blando; Hao Zhao; Shalini Singh Yadav; Martina Ott; Ling Y Kong; Amy B Heimberger; John de Groot; Boris Sepesi; Michael Overman; Scott Kopetz; James P Allison; Dana Pe'er; Padmanee Sharma
Journal:  Nat Med       Date:  2019-12-23       Impact factor: 53.440
  1 in total
  85 in total

1.  Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.

Authors:  Silke Eisinger; Dhifaf Sarhan; Vanessa F Boura; Itziar Ibarlucea-Benitez; Sofia Tyystjärvi; Ganna Oliynyk; Marie Arsenian-Henriksson; David Lane; Stina L Wikström; Rolf Kiessling; Tommaso Virgilio; Santiago F Gonzalez; Dagmara Kaczynska; Shigeaki Kanatani; Evangelia Daskalaki; Craig E Wheelock; Saikiran Sedimbi; Benedict J Chambers; Jeffrey V Ravetch; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

2.  Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.

Authors:  Jessica A Castrillon; Charis Eng; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 3.  Tumour immunotherapy: lessons from predator-prey theory.

Authors:  Phineas T Hamilton; Bradley R Anholt; Brad H Nelson
Journal:  Nat Rev Immunol       Date:  2022-05-05       Impact factor: 53.106

Review 4.  Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.

Authors:  Zachary R Stephen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2020-11-25       Impact factor: 9.933

Review 5.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 6.  Developmental pathways of myeloid-derived suppressor cells in neoplasia.

Authors:  Scott I Abrams
Journal:  Cell Immunol       Date:  2020-12-16       Impact factor: 4.868

7.  Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists.

Authors:  Roberto Butera; Marta Ważyńska; Katarzyna Magiera-Mularz; Jacek Plewka; Bogdan Musielak; Ewa Surmiak; Dominik Sala; Radoslaw Kitel; Marco de Bruyn; Hans W Nijman; Philip H Elsinga; Tad A Holak; Alexander Dömling
Journal:  ACS Med Chem Lett       Date:  2021-04-28       Impact factor: 4.345

Review 8.  Research advances on the immune research and prospect of immunotherapy in pituitary adenomas.

Authors:  Ding Nie; Qiuyue Fang; Bin Li; Jianhua Cheng; Chuzhong Li; Songbai Gui; Yazhuo Zhang; Peng Zhao
Journal:  World J Surg Oncol       Date:  2021-06-05       Impact factor: 2.754

Review 9.  Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review).

Authors:  Sanjay Anand; Timothy A Chan; Tayyaba Hasan; Edward V Maytin
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-10

Review 10.  Circadian regulation of cancer cell and tumor microenvironment crosstalk.

Authors:  Wenjing Xuan; Fatima Khan; Charles David James; Amy B Heimberger; Maciej S Lesniak; Peiwen Chen
Journal:  Trends Cell Biol       Date:  2021-07-13       Impact factor: 20.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.